Division of Cardiology, Osaka Rosai Hospital, 1179-3, Nagasone-cho, Kita-ku, Sakai, Osaka, 591-8025, Japan.
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Heart Vessels. 2021 Aug;36(8):1212-1218. doi: 10.1007/s00380-021-01795-1. Epub 2021 Mar 21.
Although several studies have suggested that catheter ablation (CA) of atrial fibrillation (AF) can improve left ventricular ejection fraction (LVEF) in patients with heart failure with reduced ejection fraction (HFrEF), the predictor of improvement of LVEF is unclear. A total of 401 patients with persistent AF underwent an initial CA between September 2014 and October 2019 in our hospital. Among them, we analyzed consecutive patients with moderately or severely reduced LVEF (< 50%) measured by transthoracic echocardiography (TTE) within 2 months before CA and underwent follow-up TTE during sinus rhythm at 6 months or more after CA. These patients were categorized into two groups: improve group (I group) with the absolute improvement of LVEF ≥ 10% at follow-up TTE, and non- improve group (NI group) with the absolute improvement of LVEF < 10% at follow-up TTE. We compared patient characteristics, ablation procedures, and clinical outcomes between the two groups. 81 patients were analyzed, and I group consisted of 48 patients (59%). In the univariate analysis, absence of ischemic cardiomyopathy, left ventricular end-diastolic diameter (LVEDD), and absence of recurrence of AF between 3 and 6 months after CA were associated with improvement of LVEF. A receiver operating characteristics analysis determined the suitable cut-off value for LVEDD was 53 mm (sensitivity: 62.2%, specificity: 86.2%, area under curve: 0.762). A multivariate analysis showed that LVEDD < 53 mm was independently associated with improvement of LVEF (odds ratio 2.58, 95% confidence interval 1.29-6.12; P = 0.021). In conclusion, LVEDD < 53 mm might be an independent predictor of improvement of LVEF after CA of persistent AF in HFrEF patients.
尽管几项研究表明,心房颤动(AF)的导管消融(CA)可以改善射血分数降低的心力衰竭(HFrEF)患者的左心室射血分数(LVEF),但 LVEF 改善的预测因素尚不清楚。在我院,共有 401 例持续性 AF 患者于 2014 年 9 月至 2019 年 10 月接受了首次 CA。其中,我们分析了连续的、经胸超声心动图(TTE)在 CA 前 2 个月内测量的中度或重度 LVEF(<50%)降低的患者,并在 CA 后 6 个月或以上窦性心律时进行了随访 TTE。这些患者分为两组:在随访 TTE 时 LVEF 绝对改善≥10%的改善组(I 组)和 LVEF 绝对改善<10%的非改善组(NI 组)。我们比较了两组患者的特征、消融程序和临床结局。分析了 81 例患者,其中 I 组有 48 例(59%)。在单因素分析中,无缺血性心肌病、左心室舒张末期直径(LVEDD)和 CA 后 3-6 个月内 AF 复发与 LVEF 改善相关。受试者工作特征分析确定 LVEDD 的合适截断值为 53mm(灵敏度:62.2%,特异性:86.2%,曲线下面积:0.762)。多因素分析表明,LVEDD<53mm 与 LVEF 改善独立相关(比值比 2.58,95%置信区间 1.29-6.12;P=0.021)。总之,LVEDD<53mm 可能是 HFrEF 患者持续性 AF 消融后 LVEF 改善的独立预测因素。